Kanał AONC
AO

American Oncology Network, Inc.

AONC · OTC

$11.00 +0.00% (+$0.00)
1M -1.08%
Market Cap $321.7M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
50 /100
Fair
EV/EBITDA 223.83x
P/S 0.18x
P/FCF 6.06x
Growth
78 /100
Growing
Rev. growth 23.08%
Book val. growth 60.84%
EPS growth N/A
Profitability
9 /100
Weak
Gross margin 6.70%
Net margin 0.23%
FCF margin 3.02%
Quality
22 /100
Poor
ROIC 7.15%
ROA 0.84%
Asset turnover 3.74x
Debt
11 /100
High
Debt/Equity 7.85x
Current ratio 1.53x
Net debt/EBITDA 46.57x
Stability
45 /100
Moderate
Beta 0.53x
Rev. volatility 13.23%
Profitable years 0

Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej

Zapytaj StockBota o AONC
Online

O spółce

American Oncology Network, Inc. (AONC) is a U.S.-based healthcare company specializing in providing oncology services. The company offers a wide range of treatment and support services for cancer patients, including chemotherapy, radiation therapy, and advanced diagnostics. American Oncology Network focuses on delivering personalized care with an emphasis on improving patients' quality of life. With its team of experienced professionals and a network of state-of-the-art facilities, the company is a key player in the field of oncology care. American Oncology Network, Inc. (AONC) shares could be suitable for investors looking to invest in healthcare with a focus on oncology and innovative treatment methods.

Opis nie jest jeszcze dostępny w Twoim języku, więc tekst jest po angielsku.

Sector

Healthcare

Industry

Medical - Care Facilities

CEO

Todd Schonherz

Employees

1,914

Headquarters

Fort Myers

Używamy niezbędnych plików cookie do działania strony oraz opcjonalnych analitycznych plików cookie do pomiaru ruchu. Zobacz naszą Politykę prywatności.